Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Biomaterials and Nanoparticle-Based Therapeutics in Neurodegenerative Diseases: Bridging the Gap Between Innovation and Translation.
The national neuromyelitis optica spectrum disorders registry system of Iran (NMORI): Aspects and methodological dimensions.
MOG-IgG Positivity Does Not Equal MOGAD: Diagnostic Pitfall and Misapplication of the International MOGAD Panel Proposed Criteria in Real-World Practice.
Recalibration and external validation of vascular risk calculators for multiple sclerosis: A population-based study using CPRD data in England, 1987-2023.
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis.
Video Head Impulse Testing in Relapsing Remitting Multiple Sclerosis: Evaluation of Canal Gains, Asymmetry, and Corrective Saccades with Cerebellar Lesions.
Clinical, Electrophysiological, and Neuropathological Features of Peripheral Neuropathies in People With T-Cell Lymphoproliferative Disorder.
Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.
Aging beyond diagnosis: the MRI brain age gap across disorders.
Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG-seronegative NMOSD.
Longitudinal changes of choroid plexus volumes and MRI ratios in multiple sclerosis.
AI-driven multimodal retinal imaging for early detection and risk stratification of vascular and neurodegenerative diseases.
Characterizing virtual community exercise programs for people with mobility limitations: a scoping review.
DNA methylation mediates the multiple sclerosis onset risk associated with HHV-6 DNA positivity.
Magnetic susceptibility source separation (χ-separation) in quantitative susceptibility mapping.
The effect of linoderm ointment, containing evening primrose oil, phonophoresis on symptoms of peripheral neuropathy in patients with type 2 diabetes.
Neurodegenerative and inflammatory biomarkers are detectable in saliva in multiple sclerosis.
Machine learning-based identification of multidimensional predictors of quality of life in individuals with multiple sclerosis.
Longitudinal Spinal Cord Atrophy in Patients With Neuromyelitis Optica Spectrum Disorder and Its Association With Rituximab Treatment.
Functional connectivity dynamics of monoaminergic circuits related to fatigue in multiple sclerosis.
Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications.
Microglia and neuroinflammation: function, heterogeneity, and crosstalk.
Vitamin D for multiple sclerosis as an adjuvant therapy: A network meta-analysis of randomized controlled trials.
Confident Identification and Quantification of Mouse Brain Tissues Reveals Sirtuin 5-Dependent Regulation.
AI and radiomics for improving the medical workflow for Multiple Sclerosis.
Pages
« first
‹ previous
…
828
829
830
831
832
833
834
835
836
…
next ›
last »